Discover

WAT
Waters Corporation
309.87
120 x 295.63
40 x 325.00
bid
ask
-
1.33
0.43%
80 @ 04:00 PM
308.88 -0.99 (0.32%)
Ytd -18.42%
1y -9.05%
307.32
day range
315.88
277.72
52 week range
412.54
Open 307.32 Prev Close 311.20 Low 307.32 High 315.88 Mkt Cap 30.42B
Vol 850.93K Avg Vol 1.18M EPS 10.72 P/E 28.91 Forward P/E 19.05
Beta 1.20 Short Ratio 2.98 Inst. Own 63.15% Dividend N/A Div Yield N/A
Ex Div Date 11-26 Earning 05-05 50-d Avg 312.26 200-d Avg 335.47 1yr Est 385.50
Earning
Date For Estimate Reported Surprise surprise %
2026-05-05 2026-03 2.31 N/A N/A N/A
2026-02-09 2025-12 4.5 4.53 0.03 0.67%
2025-11-04 2025-09 3.21 3.4 0.19 5.92%
2025-08-04 2025-06 2.93 2.95 0.02 0.68%
2025-05-06 2025-03 2.22 2.25 0.03 1.35%
2025-02-12 2024-12 4.02 4.1 0.08 1.99%
Upgrade / Downgrade
Date Firm Action From To
2026-04-13 UBS Upgrade Neutral Neutral
2026-03-25 Deutsche Bank Upgrade Hold Hold
2026-02-23 Morgan Stanley Upgrade Equal-Weight Equal-Weight
2026-02-11 Wells Fargo Upgrade Equal-Weight Equal-Weight
2026-02-10 UBS Upgrade Neutral Neutral
2026-02-10 Guggenheim Upgrade Buy Buy
Profile
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Insider Holder
Date Name Relation Quantity Description
2026-02-24 BATRA UDIT Chief Executive Officer 36.56K Stock Award(Grant)
2026-02-24 BENNETT JIANQING Officer 7.24K Stock Award(Grant)
2026-02-24 CARPIO ROBERT L III Officer 3.62K Stock Award(Grant)
2026-02-24 CHAUBAL AMOL Chief Financial Officer 8.51K Stock Award(Grant)
2026-03-05 FEARON RICHARD H Director 3.30K Purchase
2026-02-24 HUANG PEARL S. Director 3.28K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Vanguard Group Inc 7.47M 2.31B 7.61%
2025-12-30 Blackrock Inc. 5.43M 1.68B 5.53%
2025-12-30 Fundsmith LLP 3.56M 1.10B 3.62%
2025-12-30 State Street Corporation 2.68M 831.24M 2.73%
2025-12-30 Massachusetts Financial Services Co. 2.62M 813.14M 2.67%
2025-12-30 Alliancebernstein L.P. 2.07M 640.32M 2.11%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 1.88M 581.09M 1.91%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 1.50M 465.11M 1.53%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 1.30M 401.44M 1.32%
2026-02-27 iShares Trust-iShares Core S&P 500 ETF 1.25M 388.17M 1.28%
2026-02-27 Fidelity Concord Street Trust-Fidelity 500 Index Fund 1.25M 387.67M 1.27%
2026-03-30 SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust 1.15M 355.11M 1.17%
Dividend
Dividend Date
0.16 1996-11-26
Split
Split Date
2 : 1 2000-08-28
2 : 1 1999-06-11